Find investors
← Back to all investors
PM
ResearchedAngel Investors

Peter Max

Partner

Angel InvestorsSeed Round
Pitch Peter

Get their honest, personalized take on your startup.

Sign in to pitch Peter

At a glance

Full Name
Peter Max
Title
CEO & Partner
Firm
Gemstone Capital (formerly / alongside 1CT)
Firm Type
Angel / private investor and corporate-finance advisory (capital raising, pre-IPO, IPO and M&A advisory)
Investment Stage
Seed and pre-IPO growth financing
Check Size
Not personally disclosed; Gemstone-advised transactions have ranged from ~1.2M SEK / 12M DKK on the small end, and Peter has personally worked transactions from ~25M DKK up to ~13bn DKK across his career
Target Company Profile
High-caliber Nordic growth companies ("Gemstones") pursuing market leadership — qualified IPO candidates in tech, and life-science SMEs on a path to profitability
Sector Focus
Technology / IT, life sciences & biotech, and corporate finance
Geographic Focus
Nordics, with deep expertise in Denmark and Sweden
Location
Gl. Holte (2840 Holte), outside Copenhagen, Denmark

Background

Peter Max (born 1961) is a Danish executive and investor with more than three decades of top-management experience in technology and business development. He has held senior executive roles at companies including Microsoft, Apple, TDC and ZyXEL, and describes having done business in 50+ countries, started subsidiaries across most of Europe, and worked on transactions ranging from roughly 25M DKK up to 13bn DKK. Across 20+ years he has cycled through the roles of CEO, chairman, investor, founder and advisor. He holds a bachelor's degree in marketing and has taken management/MBA coursework at INSEAD and Henley.

Since 2008 he has been founder and partner of Gemstone Capital, a Nordic corporate-finance advisory firm headquartered near Copenhagen (Hellerup) that provides capital raising, IPO/listing advisory and M&A services to growth companies. He has led the firm as CEO & Partner, and is described as CEO since 2017. Gemstone Capital operates as a tied agent to the Swedish securities firm Bergs Securities AB (regulated by Finansinspektionen). His only other Gemstone-era team member publicly listed is Associate Director Sadjad Hassani.

Peter is also a long-standing partner at 1CT — the entity that led to Gemstone Capital and the source of his [hidden] address — where since around 2009 he has delivered international business development and strategic-finance services, acting both as CEO and board member on transactions. Through his personal holding company Maxelle Management ApS (which he has directed for ~25 years) he holds and manages a range of business interests. He is married and lives with his family outside Copenhagen.

His current board portfolio reflects a tech-plus-life-science focus: he was elected Chairman of the Board of Clinical Laserthermia Systems AB (CLS) at an extraordinary general meeting on 21 October 2024, and he sits on the boards of Sophion Bioscience A/S and Realfiction Holding AB.

Investment Thesis & Focus

  • Invests in and advises Nordic growth companies pursuing market leadership — internally branded "Gemstones" — spanning seed-stage through pre-IPO and public-listing.
  • Strong tilt toward technology/IT and life-science SMEs; Gemstone explicitly offers investors "access to qualified IPO candidates within the tech sector."
  • Frames the opportunity for angels/private investors as "real return with managed risk through carefully selected investment cases with reasonable valuation" — valuation discipline and downside management are central to the pitch.
  • Values companies with a credible path to profitability and financing needs he can help solve — e.g., CLS was backed on the thesis that his "long experience in growing life-science SMEs" and financing expertise would support its route to profitability.
  • Brings hands-on operational credibility (former senior executive at Microsoft, Apple, TDC, ZyXEL) rather than passive capital — he typically takes board or chairman roles alongside investment.

Notable Investments

  • Clinical Laserthermia Systems AB (CLS) — Nasdaq First North–listed Swedish medtech developing laser immunotherapy (TRANBERG) for cancer; Peter joined as Chairman of the Board in October 2024.
  • Sophion Bioscience A/S — Ballerup, Denmark; global maker of automated patch-clamp / ion-channel screening instruments for drug discovery. Peter is a board member (also of holding vehicles Sapphire/Sapphire Bioscience Holding ApS).
  • Realfiction Holding AB — Copenhagen-founded developer of 3D holographic/mixed-reality display technology (Dreamoc, DeepFrame); Peter serves on the board of Realfiction ApS and Realfiction Holding AB.
  • 1CT — his long-standing partnership/vehicle for international business development and strategic-finance transactions since ~2009; precursor to Gemstone Capital.
  • Maxelle Management ApS — personal holding company (100%-owned) through which he holds and manages investments.

Unlock the full research

Get how to approach them, recent activity, sources, contact links — plus pitch their AI twin for a candid read on your raise.

One-time. Stays unlocked for you.